Bicoll announces a new Advisory Board member – Dr. Michael Bogenstaetter officially appointed to join Bicoll's Advisory Board

Munich, Germany – June 3, 2009 – The Bicoll GmbH, a biopharmaceutical company specializing in
high-tech natural product chemistry to identify novel small molecules for drug discovery and related
innovative fields, today announces the appointment of Dr. Michael Bogenstaetter as new member of
the Advisory Board. After a one year period of getting acquainted with Bicoll’s business model and
business segments, Dr. Bogenstaetter will now officially join the long-term advisors Dr. Hardy
Debuch, Prof. Dr. Thorsten Bach, Prof. Dr. Peter Vollhardt and Sina Afra.
BIO International 2024June 3-6
+ +